Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

New York, Jan 27, 2026, 05:58 (EST) — Premarket

Dow futures slipped early Tuesday as UnitedHealth fell on news of a proposed Medicare Advantage rate update. Meanwhile, S&P 500 and Nasdaq futures climbed, with investors gearing up for a packed earnings slate and the start of the Federal Reserve meeting. By 5:22 a.m. ET, Dow E-minis were down 40 points, or 0.08%. S&P 500 E-minis gained 17.25 points, or 0.25%, and Nasdaq 100 E-minis jumped 140 points, or 0.54%. UnitedHealth, set to report earnings before the open, dropped 8.6%. Salesforce rose 2.2% after securing a $5.6 billion contract with the U.S. Army. Traders also kept an eye on consumer confidence figures and the looming January 30 U.S. funding deadline. 1

The Dow is price-weighted, meaning stocks with higher prices have outsized influence, often moving the index more than their market value alone would imply. That’s why a single policy headline, such as a Medicare update, can sway the blue-chip index more noticeably than broader benchmarks on certain mornings.

The Dow climbed 313.69 points, or 0.64%, to finish at 49,412.40 on Monday. Wall Street showed a clear preference for big tech and communications stocks ahead of a packed earnings calendar. “You’re seeing communications and technology are trading well today in advance of the earnings from a lot of the large companies,” said Chris Zaccarelli, chief investment officer at Northlight Asset Management. 2

Late Monday, the Centers for Medicare & Medicaid Services proposed a mere 0.09% bump in 2027 payments to private insurers managing Medicare Advantage plans — the government-backed coverage sold to seniors and disabled individuals. Kevin Gade, COO at Bahl & Gaynor, noted investors had been expecting a rise closer to 4% to 5%. Morningstar’s Julie Utterback said the industry will be watching closely to see if the agency tweaks its assumptions ahead of the final notice due April 6. 3

The Fed’s two-day meeting kicks off Tuesday, with most expecting the policy rate to hold steady between 3.50% and 3.75%. Tim Duy, chief U.S. economist at SGH Macro Advisors, noted that “Trump will need greater turnover at the Fed to fully control the institution,” as focus turns to leadership questions surrounding Chair Jerome Powell and the next nomination. Oxford Economics’ Michael Pearce said last week the “near-term outlook is benign,” but cautioned that outside events could still disrupt the rate trajectory. 4

Washington introduced fresh market tension as a partial government shutdown loomed amid a standoff between Republicans and Democrats over Department of Homeland Security funding, Reuters reported. The dispute follows a second fatal shooting involving federal immigration officers in Minneapolis. Republican Senator Susan Collins cautioned against a “dangerous and detrimental government shutdown” as funding for several key programs is set to expire after midnight Friday. 5

Dow traders face a familiar blend: health care policy rattles one of the index’s biggest components, even as earnings and interest rates remain front and center. If UnitedHealth manages to hold its ground post-report, the initial weakness might quickly disappear.

The risk runs the other way. A sharper selloff in insurers, cautious forecasts from industrial leaders, or a Fed signal that rates will remain elevated longer than expected might push funds back to the sidelines and hit cyclicals, which make up a large part of the Dow.

Coming up fast: UnitedHealth reports earnings before Tuesday’s open, followed by U.S. consumer confidence data later that day. Then on Wednesday, the Fed unveils its policy decision alongside Powell’s press conference. The week wraps with the government funding deadline on Friday.

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
India stock market today: Nifty, Sensex end higher on EU trade deal buzz as autos lag
Previous Story

India stock market today: Nifty, Sensex end higher on EU trade deal buzz as autos lag

ASX 200 hits three-month high as miners ride record gold and BHP retakes top spot
Next Story

ASX 200 hits three-month high as miners ride record gold and BHP retakes top spot

Go toTop